###begin article-title 0
###xml 62 86 62 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia enterocolitica </italic>
###xml 62 85 <span type="species:ncbi:630">Yersinia enterocolitica</span>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
Role of IFN-gamma and IL-6 in a protective immune response to Yersinia enterocolitica in mice
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
###xml 65 89 65 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia enterocolitica </italic>
###xml 65 88 <span type="species:ncbi:630">Yersinia enterocolitica</span>
###xml 90 92 <span type="species:ncbi:630">Ye</span>
###xml 126 128 <span type="species:ncbi:630">Ye</span>
###xml 165 167 <span type="species:ncbi:630">Ye</span>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 273 275 <span type="species:ncbi:630">Ye</span>
###xml 279 283 <span type="species:ncbi:10090">mice</span>
Yersinia outer protein (Yop) H is a secreted virulence factor of Yersinia enterocolitica (Ye), which inhibits phagocytosis of Ye and contributes to the virulence of Ye in mice. The aim of this study was to address whether and how YopH affects the innate immune response to Ye in mice.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 59 60 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 105 109 101 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH</italic>
###xml 117 119 113 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 257 269 249 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH in vivo</italic>
###xml 385 387 377 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 396 401 384 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 631 633 615 617 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 672 677 652 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 740 744 716 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 752 756 728 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 769 771 745 747 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 779 784 751 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 863 867 831 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH</italic>
###xml 943 944 911 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 52 54 <span type="species:ncbi:630">Ye</span>
###xml 82 84 <span type="species:ncbi:630">Ye</span>
###xml 756 760 <span type="species:ncbi:10090">mice</span>
###xml 1082 1084 <span type="species:ncbi:630">Ye</span>
For this purpose, mice were infected with wild type Ye (pYV+) or a YopH-deficient Ye mutant strain (DeltayopH). CD11b+ cells were isolated from the infected spleen and subjected to gene expression analysis using microarrays. Despite the attenuation of DeltayopH in vivo, by variation of infection doses we were able to achieve conditions that allow comparison of gene expression in pYV+ and DeltayopH infection, using either comparable infection courses or splenic bacterial burden. Gene expression analysis provided evidence that expression levels of several immune response genes, including IFN-gamma and IL-6, are high after pYV+ infection but low after sublethal DeltayopH infection. In line with these findings, infection of IFN-gammaR-/- and IL-6-/- mice with pYV+ or DeltayopH revealed that these cytokines are not necessarily required for control of DeltayopH, but are essential for defense against infection with the more virulent pYV+. Consistently, IFN-gamma pretreatment of bone marrow derived macrophages (BMDM) strongly enhanced their ability in killing intracellular Ye bacteria.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 198 200 <span type="species:ncbi:630">Ye</span>
In conclusion, this data suggests that IFN-gamma-mediated effector mechanisms can partially compensate virulence exerted by YopH. These results shed new light on the protective role of IFN-gamma in Ye wild type infections.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 0 24 0 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia enterocolitica </italic>
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 259 260 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 403 412 403 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
###xml 444 445 444 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 567 568 567 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 815 816 815 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 963 964 963 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 965 966 965 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1088 1089 1088 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1090 1091 1090 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1325 1326 1325 1326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1327 1329 1327 1329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1443 1445 1443 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1575 1584 1575 1584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
###xml 1766 1775 1766 1775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
###xml 1776 1778 1776 1778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1939 1941 1939 1941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 0 23 <span type="species:ncbi:630">Yersinia enterocolitica</span>
###xml 25 27 <span type="species:ncbi:630">Ye</span>
###xml 274 276 <span type="species:ncbi:630">Ye</span>
###xml 1495 1499 <span type="species:ncbi:10090">mice</span>
Yersinia enterocolitica (Ye) is an enteropathogenic bacterium which causes gastrointestinal disorders such as, enteritis, enterocolitis and extraintestinal manifestations such as lymphadenitis, reactive arthritis, erythema nodosum, uveitis and septicaemia [1,2]. Pathogenic Ye strains carry a 70-kb plasmid (pYV), which is essential for the pathogenicity and encodes a type III secretion system (TTSS), Yersinia outer proteins (Yops) and YadA [3]. The TTSS enables extracellularly located yersiniae to translocate at least six effector Yops directly into host cells [3]. The Yops interfere with different signaling pathways involved in the regulation of the actin cytoskeleton, phagocytosis, apoptosis and in the inflammatory response, thus favoring survival of the bacteria in an extracellular tissue compartment [3]. YopH, YopE, YopT, and YopO/YpkA disturb cytoskeletal dynamics and thereby inhibit phagocytosis by polymorphonuclear leukocytes and macrophages [4-7]. YopH, a tyrosine phosphatase, causes disruption of focal adhesion complex structures and inhibits the oxidative burst [7,8]. Among others, the host cell targets of YopH in epithelial cells are the focal adhesion proteins Crk-associated substrate (p130Cas) and focal adhesion kinase (FAK) and in macrophages p130Cas, Fyn-binding protein (Fyb) and SKAP-HOM [8-12]. YopH mutants, which are unable to bind p130Cas, do not localize to focal complex structures in infected cells [13]. These YopH mutants showed reduced virulence in mice, suggesting that binding to p130Cas and/or Fyb is biologically relevant in Yersinia infections. Other functions of YopH include the inhibition of the phosphatidyl-inositol 3 kinase (PI3K)/Akt signaling pathway which is activated in macrophages upon interaction with Yersinia [14], and downstream effects such as expression of the chemokine monocyte chemoattractant protein-1 (MCP-1, CCL2), an important chemotactic factor for macrophages [14].
###end p 9
###begin p 10
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 450 459 450 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 462 466 <span type="species:ncbi:10090">mice</span>
The phosphatase activity of YopH inhibits the ability of T cells to produce cytokines and proliferate, as well as the ability of B cells to express the B-cell co-stimulatory receptor CD86, possibly by dephosphorylating critical tyrosine residues on signaling proteins involved in T- and B-cell activation [14-17]. The biological relevance of YopH is underlined by different reports demonstrating that the lack of YopH results in reduced virulence of Yersinia in mice [18-21].
###end p 10
###begin p 11
###xml 118 136 118 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. enterocolitica </italic>
###xml 157 158 157 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 192 196 188 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH</italic>
###xml 237 239 233 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 372 374 368 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 611 629 603 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. enterocolitica </italic>
###xml 634 639 622 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 118 135 <span type="species:ncbi:630">Y. enterocolitica</span>
###xml 611 628 <span type="species:ncbi:630">Y. enterocolitica</span>
In this study, we addressed whether and how YopH might affect the innate immune response in mice. Upon infection with Y. enterocolitica O8 strain WA-314 (pYV+) or a YopH deletion mutant (DeltayopH) alterations in gene expression in CD11b+ cells was analyzed. These cells include mostly granulocytes and macrophages and to a lower extent dendritic cells and NK cells. CD11b+ cells were chosen because they are the most important spleen cell subpopulations involved in innate immune responses. The data reported herein provide strong evidence that IFN-gamma and IL-6 are not necessarily required for clearance of Y. enterocolitica DeltayopH and that IFN-gamma compensates YopH-mediated immune evasion mechanisms in macrophages.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 25 49 25 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia enterocolitica </italic>
###xml 25 48 <span type="species:ncbi:630">Yersinia enterocolitica</span>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
YopH deletion attenuates Yersinia enterocolitica in mice
###end title 13
###begin p 14
###xml 103 134 103 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia enterocolitica in vivo</italic>
###xml 255 257 255 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 266 270 262 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH</italic>
###xml 309 311 305 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 314 316 310 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 325 327 321 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 332 337 324 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 379 381 371 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 384 386 376 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 395 397 387 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 402 407 390 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 456 458 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 489 491 477 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 588 592 572 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH</italic>
###xml 625 627 609 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 635 640 615 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 696 698 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 103 126 <span type="species:ncbi:630">Yersinia enterocolitica</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
In this study, we addressed how the virulence factor YopH affects the early innate immune responses to Yersinia enterocolitica in vivo. For this purpose, we defined the inocula leading to sublethal and lethal infection after intravenous infection with pYV+ and DeltayopH. Infection of C57BL/6 mice with 5 x 103 pYV+ or 5 x 104 DeltayopH caused a sublethal infection, while 5 x 104 pYV+ or 5 x 106 DeltayopH resulted in a lethal course of infection (Figure 1A). Sublethal infection with pYV+ resulted in significantly higher bacterial counts in the spleen at day 1 p.i. compared with DeltayopH, while lethal infection with pYV+ or DeltayopH resulted in comparable bacterial splenic counts (Figure 1B).
###end p 14
###begin p 15
###xml 26 28 26 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 37 41 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH</italic>
###xml 0 41 0 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Infection of mice with pYV<sup>+ </sup>and &#916;<italic>yopH</italic></bold>
###xml 109 111 105 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 120 122 116 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 125 126 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 142 144 138 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 153 155 149 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 160 165 152 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 465 467 455 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
Infection of mice with pYV+ and DeltayopH. (A) Survival curve of C57BL/6 mice upon i.v. infection with 5 x 103 or 5 x 104 pYV+, or with 5 x 104 or 5 x 106 DeltayopH (B) The bacterial numbers in the spleen of mice and total number of (C) macrophages and (D) granulocytes in the spleen was determined 24 h after infection. The data were from two independent the means +/- standard deviation of at least ten mice per group. Asterisks indicate significant differences (p < 0.05, A and B, logrank test; C, Wilcoxon rank test, D and E, One-Way ANOVA with Dunnett test) between the compared groups.
###end p 15
###begin p 16
###xml 62 64 62 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 73 78 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 164 165 160 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 170 171 166 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 193 194 189 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 198 199 194 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 227 228 223 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 233 234 229 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 390 392 386 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 401 406 393 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 571 573 563 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 579 581 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 691 693 683 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 732 737 720 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 753 755 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 434 438 <span type="species:ncbi:10090">mice</span>
To address whether the sublethal and lethal infection with pYV+ and DeltayopH affect the cells involved in innate immune responses, the number of macrophages (CD11b+F4/80+), granulocytes (CD11b+Ly6G+) and dendritic cells (CD11b+CD11c+) in the spleen was determined at day 1 p.i. The total number of macrophages was significantly increased one day after the sublethal infection with both pYV+ and DeltayopH compared with mock-infected mice. In contrast, under lethal conditions a significant increase in the number of macrophages was only detected after infection with pYV+ (Fig. 1C). The number of granulocytes was significantly increased after sublethal as well as lethal infection with pYV+ but not after sublethal or lethal DeltayopH infection (Fig. 1D). The number of dendritic cells was similar in all conditions one day after infection (data not shown).
###end p 16
###begin p 17
###xml 72 74 72 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 83 88 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 415 417 411 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 426 431 418 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
From this data we can conclude that by variation of the inoculum for pYV+ and DeltayopH infections, conditions can be achieved that lead either to comparable infection course (lethal or sublethal) or to comparable bacterial burden in the spleen as well as to comparable alterations in the composition of splenic cell populations. These changes have to be considered when gene expression patterns are compared in pYV+ and DeltayopH infections.
###end p 17
###begin title 18
###xml 24 26 24 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 38 47 38 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
Gene expression in CD11b+ cells after Yersinia infection
###end title 18
###begin p 19
###xml 110 112 110 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 438 440 438 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 448 452 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH</italic>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
To analyse whether YopH affects gene expression in cells involved in the innate immune response, splenic CD11b+ cells were purified by MACS to 96-98% from mice one day p.i. RNA was extracted and subjected to gene expression analysis using Affymetrix MG-U74Av2 microarrays. First, we identified all genes which were more than 3-fold higher or more than 3-fold lower expressed after infection with either a sublethal or a lethal dose of pYV+ or DeltayopH compared to uninfected mice resulting in 1428 probe sets. These probe sets were used in the following analyses.
###end p 19
###begin title 20
###xml 55 57 55 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 66 71 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
Gene expression analyses reveal differences between pYV+ and DeltayopH infection
###end title 20
###begin p 21
###xml 118 120 118 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 129 133 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH</italic>
###xml 182 184 178 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 219 221 215 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 240 245 232 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 443 445 435 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 575 577 567 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 658 660 650 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 669 673 657 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH</italic>
###xml 731 733 719 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 749 754 733 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 827 829 811 813 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 1025 1027 1009 1011 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1036 1041 1016 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 1081 1082 1061 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1087 1088 1067 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1125 1126 1105 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 588 592 <span type="species:ncbi:10090">mice</span>
###xml 707 711 <span type="species:ncbi:10090">mice</span>
Two approaches were selected, to help identify immune response genes whose expression differs after infection with pYV+ and DeltayopH. In the first approach, gene expression of CD11b+ cells from mice after sublethal pYV+ and sublethal DeltayopH infection was compared. This method was used to compare gene expression associated with similar outcome of disease; however, the different bacterial splenic counts and different composition of CD11b+ subpopulations has to be considered in subsequent comparative analyses. In a second approach, we compared gene expression of CD11b+ cells from mice with comparable bacterial splenic counts after infection with pYV+ and DeltayopH. To accomplish this, we compared mice after sublethal pYV+ and lethal DeltayopH infection resulting in similar splenic bacterial counts one day p.i. (~105 CFU) in the spleen. In both approaches k-means cluster analysis was carried out to characterize groups of co-expressed genes. Genes which were more than 3-fold differentially expressed between pYV+ and DeltayopH infection are listed in Additional file 1 and 2 and depicted as heat maps in Figure 2.
###end p 21
###begin p 22
###xml 60 62 60 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 71 75 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH</italic>
###xml 0 75 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Comparison of gene expression between mice infected with pYV<sup>+ </sup>and &#916;<italic>yopH</italic></bold>
###xml 105 107 101 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 159 161 155 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 169 174 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 258 260 250 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 269 274 257 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 393 395 381 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 450 452 438 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 597 599 585 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 631 636 615 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 677 679 661 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 698 703 678 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 723 725 703 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 807 809 787 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 817 821 793 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH</italic>
###xml 1028 1030 1000 1002 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
###xml 761 765 <span type="species:ncbi:10090">mice</span>
###xml 775 779 <span type="species:ncbi:10090">mice</span>
###xml 1052 1056 <span type="species:ncbi:10090">mice</span>
Comparison of gene expression between mice infected with pYV+ and DeltayopH. Microarray analysis of CD11b+ cells isolated from spleen of mice infected with pYV+ or DeltayopH for one day. All probe sets are displayed whose SLR ratio between infection with pYV+ and DeltayopH for one day was > 1.49 or < -1.49. Heat maps indicate increased (red) or decreased (green) expression of genes in CD11b+ cells one day after infection of mice compared to CD11b+ cells from uninfected mice. The heatmaps indicate genes differentially expressed and clustered in different groups: (A, approach I) sublethal pYV+ infection versus sublethal DeltayopH infection; (B, approach II) sublethal pYV+ versus lethal DeltayopH infection. (C) CD11b+ cells were enriched from uninfected mice and from mice infected for 1 day with pYV+ or DeltayopH, and RNA was extracted. mRNA expression of IFN-gamma, IL-6, IL-12p35 and MARCO was analysed and normalized to RPL8 mRNA expression. The data represent the fold induction of mRNA expression compared to CD11b+ cells from uninfected mice. Representative data for three independent experiments are shown.
###end p 22
###begin p 23
###xml 65 67 65 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 99 104 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 188 190 184 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 209 214 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 354 356 346 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 373 374 365 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 418 423 406 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 440 441 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 583 584 567 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 593 595 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 628 629 612 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
The immune response genes identified by approach I (sublethal pYV+ infection versus sublethal DeltayopH infection) comprised genes which were more highly expressed after both sublethal pYV+ and sublethal DeltayopH infection, as compared with mock-infected mice. However, the expression level of these genes was more than 3-fold higher after sublethal pYV+ infection (Table 1, column 1) as compared with sublethal DeltayopH infection (Table 1, column 3). These genes were designated as Group 1 and included genes encoding e.g. IFN-gamma, IL-6, histidine decarboxylase and iNOS (Table 1, Figure 2A, Cluster A1 and Additional file 1).
###end p 23
###begin p 24
###xml 71 73 71 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 90 94 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH</italic>
Immune response genes differentially expressed after infection with pYV+ compared to DeltayopH
###end p 24
###begin p 25
###xml 49 51 49 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 102 107 98 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
As the bacterial splenic load after sublethal pYV+ infection was lower than that after sublethal DeltayopH infection at day 1 p.i., we cannot exclude the possibility that the different gene expression is due to the different bacterial load in the spleen.
###end p 25
###begin p 26
###xml 99 101 99 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 137 142 133 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 159 160 155 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 329 331 325 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 347 352 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 489 494 473 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 534 536 518 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Therefore, in approach II we first compared expression of Group 1 genes in mice after sublethal pYV+ (Table 1, column 1) and lethal DeltayopH infection (Table 1, column 4) which resulted in similar splenic bacterial counts 1 day p.i. The data revealed Group 1A, which included genes with comparable expression after sublethal pYV+ and lethal DeltayopH infection such as, IFN-gamma and histidine decarboxylase, and Group 1B, which included genes which were expressed less after lethal DeltayopH infection as compared with sublethal pYV+ infection.
###end p 26
###begin p 27
###xml 83 88 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 123 125 119 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 142 143 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 161 163 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 490 495 482 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 618 620 610 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 628 633 616 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 518 522 <span type="species:ncbi:10090">mice</span>
###xml 659 663 <span type="species:ncbi:10090">mice</span>
Approach II also revealed genes which were more highly expressed after lethal DeltayopH infection compared to sublethal pYV+ infection (Table 1, Group 2, Figure 2B, Cluster B2). While the expression of several of these genes (Group 2A) which include acute phase reactants such as serum amyloid alpha 3 (SAA3), lipopolysaccharide binding protein (LBP) and other genes such as MARCO, peptidoglycan recognition protein and lactotransferrin were increased only after lethal infection with DeltayopH compared to uninfected mice, others (Group 2B), e.g., IL-10 and CCL17 increased only after lethal infection either with pYV+ or DeltayopH as compared to uninfected mice.
###end p 27
###begin p 28
###xml 175 184 171 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
###xml 243 248 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 293 295 285 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Furthermore, approach II revealed genes (interferon induced genes such as interferon inducible GTPase 1 (IIGP1), CXCL9, as well as VEGF-alpha) which were highly induced after Yersinia infection but which were lower expressed after lethal DeltayopH infection compared to sublethal or lethal pYV+ infection.
###end p 28
###begin p 29
###xml 284 286 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
To ensure that the results obtained by microarray analyses can be reproduced by other methods, mRNA expression analyses for IFN-gamma, IL-6, IL-12p35 and MARCO were performed by Real-time RT PCR. The results obtained were comparable to those obtained by microarraray analyses (Figure 2C).
###end p 29
###begin title 30
###xml 65 83 61 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. enterocolitica </italic>
###xml 88 92 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH</italic>
###xml 65 82 <span type="species:ncbi:630">Y. enterocolitica</span>
IFN-gamma and IL-6 are not necessarily required for clearance of Y. enterocolitica DeltayopH
###end title 30
###begin p 31
###xml 130 132 126 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 175 180 167 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 205 207 197 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 287 289 279 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 305 309 293 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH</italic>
###xml 422 424 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 425 427 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 592 595 572 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 605 609 585 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 638 643 614 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 649 651 625 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 727 728 703 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 753 755 729 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 832 837 804 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 856 859 824 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 865 869 833 837 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 985 989 949 953 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 997 1001 961 965 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1057 1058 1021 1022 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1123 1127 1083 1087 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1135 1139 1095 1099 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1197 1201 1153 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH</italic>
###xml 1308 1313 1256 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 398 400 <span type="species:ncbi:630">Ye</span>
###xml 523 525 <span type="species:ncbi:630">Ye</span>
###xml 609 613 <span type="species:ncbi:10090">mice</span>
###xml 882 886 <span type="species:ncbi:10090">mice</span>
###xml 1001 1005 <span type="species:ncbi:10090">mice</span>
###xml 1028 1032 <span type="species:ncbi:10090">mice</span>
###xml 1139 1143 <span type="species:ncbi:10090">mice</span>
###xml 1166 1170 <span type="species:ncbi:10090">mice</span>
The data presented above revealed that in self-limiting infections (sublethal), the expression of both IFN-gamma and IL-6 in CD11b+ cells increased significantly less in DeltayopH infection compared to pYV+ infection, suggesting that these cytokines might be necessary for control of pYV+ but not of DeltayopH. From earlier studies, it is known that IFN-gamma and IL-6 are crucial for clearance of Ye wild type infection [22,23]. To investigate whether these cytokines are in fact dispensable for the early defense against Ye lacking the virulence factor YopH, wild type (C57BL/6), IFN-gammaR-/-, and IL-6-/- mice were infected with DeltayopH or pYV+ and the bacterial numbers in the spleen were determined. As shown in Figure 3, upon infection with pYV+ the bacterial burden was higher at all investigated time points than in DeltayopH infected IFN-gammaR-/-, IL-6-/- or wild type mice. 72 hours p.i., the bacterial burden was significantly higher (p < 0.05) in spleens of IFN-gamma-R-/- and IL-6-/- mice compared to wild type mice after infection with pYV+. In contrast, a similar bacterial burden was found in IFN-gammaR-/- and IL-6-/- mice compared to wild type mice after infection with DeltayopH. From this data, we conclude that IFN-gamma and IL-6 are not necessarily required for the control of DeltayopH infection at least in the early phase of infection.
###end p 31
###begin p 32
###xml 76 81 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 0 90 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IFN-&#947;R and IL-6 are not necessarily required for the control of Ye &#916;<italic>yopH </italic>infection</bold>
###xml 102 106 90 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 117 121 105 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 193 195 181 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 198 200 186 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 222 224 210 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 229 234 213 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 358 361 342 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10 </sub>
###xml 505 507 489 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 68 70 <span type="species:ncbi:630">Ye</span>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 444 448 <span type="species:ncbi:10090">mice</span>
IFN-gammaR and IL-6 are not necessarily required for the control of Ye DeltayopH infection. IFN-gammaR-/- (A) or IL-6-/- (B) mice as well as C57BL/6 mice were infected intravenously with 5 x 104 pYV+ (black bars) or 5 x 104 DeltayopH (white bars). The bacterial number was assessed in spleens 24 and 72 hours after infection. Values represent the average log10 CFU per spleen with the standard errors of the means indicated by error bars (5-10 mice per group). Asterisks indicate significant differences (p < 0.05, Wilcoxon Rank test) between the compared groups. Two further independent experiments showed comparable results.
###end p 32
###begin title 33
IFN-gamma pretreatment compensates YopH mediated inhibition of bacterial killing by BMDM
###end title 33
###begin p 34
###xml 420 422 408 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 430 434 414 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH</italic>
###xml 65 67 <span type="species:ncbi:630">Ye</span>
To address whether the importance of IFN-gamma, in counteracting Ye infection, could be linked to the defense against YopH mediated virulence, we investigated whether YopH may counteract the killing of yersiniae by BMDM. In addition, we tested whether IFN-gamma improves the killing of yersiniae by BMDMs. For this purpose, BMDM were cultured with and without IFN-gamma for 24 h and subsequently infected with either pYV+ or DeltayopH. The number of bacteria was determined 0.25 hours after the infection of BMDM; alternatively BMDM were treated after 0.25 hours with gentamicin and the intracellular survival of bacteria was determined 3 and 5 hours after infection.
###end p 34
###begin p 35
###xml 116 117 116 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 256 258 252 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 275 280 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 359 364 343 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 451 453 431 433 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 563 565 539 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 574 579 546 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 641 643 613 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 718 723 682 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 843 848 795 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 911 912 863 864 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 211 213 <span type="species:ncbi:630">Ye</span>
At 0.25 hours after the infection, the number of bacteria associated with BMDM was comparable in all groups (Figure 4) suggesting that neither pretreatment of BMDM with IFN-gamma nor YopH affects association of Ye with BMDM. At three hours p.i., 7 % of pYV+ and 2.1% of DeltayopH were viable in BMDM cultured without IFN-gamma indicating that killing of DeltayopH by BMDM cultured without IFN-gamma was significantly more effective than killing of pYV+ (p < 0.01). Interestingly, pretreatment of BMDM with IFN-gamma significantly increased the killing of both pYV+ and DeltayopH by more than 60 %. This data indicates that the killing of pYV+ by BMDM, pretreated with IFN-gamma, is as effective as the killing of DeltayopH by BMDM culture without IFN-gamma, suggesting that IFN-gamma- mediated mechanisms are not necessarily required for DeltayopH infection but contribute to an effective immune response to pYV+.
###end p 35
###begin p 36
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Survival of bacteria in BMDM</bold>
###xml 145 147 141 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 155 160 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 501 503 491 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
Survival of bacteria in BMDM. BMDM were either pretreated or not pretreated with IFN-gamma (50 ng/ml) for 24 h and subsequently infected with pYV+ or DeltayopH with a MOI of 5 (C) for 0.25 or three hours as described in Material and Methods. Numbers of bacteria were determined by a CFU assay. The data represent the CFU +/- standard deviation of three independent experiments. All groups were compared for one point in time and asterisks indicate significant differences between the compared groups (p < 0.05, one-way ANOVA with Bonferroni correcctions).
###end p 36
###begin title 37
Discussion and conclusion
###end title 37
###begin p 38
###xml 216 217 216 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 55 57 <span type="species:ncbi:630">Ye</span>
###xml 103 105 <span type="species:ncbi:630">Ye</span>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
YopH is one of the most important virulence factors of Ye, which promotes colonization and survival of Ye in lymphoid tissues of mice. This capability appears to be attributed to its ability to inhibit phagocytosis [5,24]. and T cell activation through the intracytoplasmic action of YopH in phagocytes and T cells, respectively [15-17].
###end p 38
###begin p 39
###xml 111 118 111 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 199 201 199 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 209 214 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 236 238 232 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 283 285 279 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
###xml 522 524 <span type="species:ncbi:630">Ye</span>
The goal of this study was to investigate whether and how YopH might interfere with the innate immune response in vivo. To this end, the gene expression profiles prior to and after infection with pYV+ or DeltayopH were analyzed in CD11b+ cells from the spleen of infected mice. CD11b+ cells were chosen because they represent the most important spleen cell subpopulation involved in innate immune responses such as granulocytes, macrophages, and dendritic cells and have been demonstrated to be involved in or targeted by Ye infection.
###end p 39
###begin p 40
###xml 23 31 23 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 141 148 141 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 499 501 499 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1419 1424 1415 1420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 1441 1446 1433 1438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 45 47 <span type="species:ncbi:630">Ye</span>
###xml 138 140 <span type="species:ncbi:630">Ye</span>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 235 237 <span type="species:ncbi:630">Ye</span>
###xml 362 364 <span type="species:ncbi:630">Ye</span>
###xml 606 608 <span type="species:ncbi:630">Ye</span>
###xml 710 714 <span type="species:ncbi:10090">mice</span>
###xml 776 778 <span type="species:ncbi:630">Ye</span>
###xml 936 940 <span type="species:ncbi:10090">mice</span>
###xml 995 997 <span type="species:ncbi:630">Ye</span>
The major problem with in vivo studies using Ye mutants is that mutations in major pathogenicity factors such as YopH affect virulence of Ye in vivo. Consequently, infection of mice with the same infection dose of wild type and mutant Ye ultimately results in different bacterial burden in infected organs. This gives rise to (i) different immune stimulation by Ye compounds and, as demonstrated herein, (ii) different recruitment of inflammatory cells and hence (iii) different composition of CD11b+ spleen cell subpopulations. As a result, the differences in gene expression between wild type and mutant Ye might reflect both direct and indirect effects of virulence factors such as YopH. As an alternative, mice can be infected with different doses of wild type and mutant Ye, which will lead to comparable bacterial burden in infected organs such as the spleen. In this study we used both approaches and compared gene expression in mice infected with identical doses of wild type and mutant Ye (leading to different bacterial burden and clinical outcome) and variable doses (leading to comparable bacterial burden and clinical outcome). However, in the latter approach we could not rule out effects in gene expression that may result from different spleen cell subpopulations. Additional comparisons were performed, such as comparison of sublethal wildtype with lethal wildtype infection, as well as sublethal DeltayopH with lethal DeltayopH infection because the information obtained was mostly redundant to those already received with the comparisons discussed below.
###end p 40
###begin p 41
###xml 94 96 94 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 112 117 108 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 379 381 375 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 397 402 389 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 614 616 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 643 648 631 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 673 674 661 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 811 813 799 801 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 829 834 813 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 996 1001 976 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
We focused on the differences in genes known to be involved in immune responses. Sublethal pYV+ and lethal DeltayopH infection results in the same bacterial burden in the spleen but shows some differences in the composition of the cell populations expressing CD11b such as granulocytes, macrophages and dendritic cells. However, comparison of the expression between sublethal pYV+ and lethal DeltayopH infection reveals that acute phase reactants and other genes involved in innate immune response such as the antimicrobial component lactoferrin and MARCO (playing a role in clearance of pneumococcal infections) [25] are increased after DeltayopH infection compared to pYV+infection. Since acute phase reactants are predominantly constitutively expressed, the differences in gene expression after sublethal pYV+ and lethal DeltayopH infection may be due to changes in the composition of the cell populations which express CD11b but nevertheless may be also associated with lethal course of DeltayopH infection.
###end p 41
###begin p 42
###xml 69 71 69 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 88 90 88 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 146 151 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 417 419 413 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 570 572 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 645 647 641 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 705 709 701 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 715 717 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 855 864 851 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
###xml 1010 1012 1006 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1174 1176 1170 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1177 1179 1173 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 471 473 <span type="species:ncbi:630">Ye</span>
###xml 676 680 <span type="species:ncbi:10090">mice</span>
###xml 709 713 <span type="species:ncbi:10090">mice</span>
IL-10 and CCL17 were found to be higher expressed after sublethal pYV+ versus lethal pYV+ infection as well as after sublethal versus lethal DeltayopH infection, respectively. Since each of these conditions was associated with a comparable composition of the cell populations expressing CD11b in the spleen we conclude that increased expression of IL-10 and CCL17 is not due to differences in the composition of CD11b+ cells. Previous studies suggested that the secreted Ye protein LcrV of O8 strains binds to TLR2 and triggers increased IL-10 secretion in macrophages [26]. In line with this, it was shown that infection with an inocolum of pYV+ which is lethal for wildtype mice can be survived by IL-10-/- mice [27] indicating that IL-10 is a marker for lethal or sublethal course of infection. However, this might not be a general observation for all Yersinia strains or species since TLR2 activity and probably IL-10 secretion induced by LcrV vary due to a hypervariable region in the N-terminus of LcrV [28]. In addition, the highest TLR2 activity was found for O8 strains as used in this study. Likewise, CCL17, a chemokine which attracts Th2 and regulatory T cells [29-31]. could also be involved in driving infections in direction of a lethal course; this, however, has to be more thorougly investigated in further studies.
###end p 42
###begin p 43
###xml 76 81 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 672 674 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 779 784 763 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 896 901 876 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 1176 1181 1148 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 1192 1194 1164 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1312 1317 1276 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 1419 1423 1379 1383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1474 1478 1434 1438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1555 1560 1511 1516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 658 660 <span type="species:ncbi:630">Ye</span>
###xml 1423 1427 <span type="species:ncbi:10090">mice</span>
###xml 1478 1482 <span type="species:ncbi:10090">mice</span>
Since a high number of genes showed a lower expression after sublethal DeltayopH infection we focused predominantly on this aspect. Within this group several proinflammatory response genes dependent on TLR signaling such as IL-12, CXCL1, CXCL2 and TNF-alpha but also IFN-gamma were predominantly found. Since cytokines and chemokines act as secreted proteins the overall expression levels may be of more relevance than the subpopulation of cells which expresses these genes. In addition, histidine decarboxylase was found in this group of genes. The expression of histidine decarboxylase seems to reflect the importance of histamine signaling for control of Ye infection [32]. The improved reduction of the bacterial burden as found after infection with a sublethal dose of DeltayopH is associated with a lower expression of such genes. The weaker immune response found after infection with DeltayopH may reflect the more effective clearance of bacteria but may also raise the possibility that components of this immune response are no longer required to control the infection. Previous data suggested that IL-12, IL-18 and TNF-alpha may not be required for clearance of DeltayopH infection [19]. In line with these findings we have shown that IFN-gamma and IL-6 may also not be required for clearance of a DeltayopH infection. Thus, clearance of infection in the spleen is comparable in C57BL/6 and congenic IFN-gammaR-/- mice. Similar experiments were performed using IL-6-/- mice, indicating that IL-6 is not necessarily required for clearance of DeltayopH infection.
###end p 43
###begin p 44
###xml 61 88 61 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. pseudotuberculosis yopH </italic>
###xml 186 190 182 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 203 207 195 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 213 215 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 216 218 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 255 277 247 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. pseudotuberculosis </italic>
###xml 291 296 283 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 366 371 354 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 517 539 501 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. pseudotuberculosis </italic>
###xml 555 560 539 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 583 585 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 669 678 649 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
###xml 679 681 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 728 733 704 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 801 823 777 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. pseudotuberculosis </italic>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 61 82 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 255 276 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
###xml 517 538 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
###xml 801 822 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
###xml 827 829 <span type="species:ncbi:630">Ye</span>
###xml 843 847 <span type="species:ncbi:10090">mice</span>
Other groups found that oral infection of BALB/c mice with a Y. pseudotuberculosis yopH mutant resulted in a similar bacterial burden in the spleen five days after infection of IFN-gamma-/- and IFN-gamma+/+ mice [20,21]. Interestingly, by co-infection of Y. pseudotuberculosis wild type and yopH mutant it has been demonstrated that in the presence of IFN-gamma the yopH mutant is more efficiently killed in comparison to wild type. On the contrary, in the absence of IFN-gamma the survival advantage of the wildtype Y. pseudotuberculosis compared to the yopH mutant is much weaker [20]. This data supports the view that IFN-gamma is required for clearance of wildtype Yersinia [22] but plays a minor role for clearance of DeltayopH mutant and would explain at least in this case similarities between Y. pseudotuberculosis and Ye infection of mice.
###end p 44
###begin p 45
###xml 190 192 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 236 238 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 320 329 312 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
###xml 512 516 500 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH</italic>
###xml 521 523 509 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 843 852 823 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
###xml 975 977 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 978 980 958 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1297 1299 1277 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 411 413 <span type="species:ncbi:630">Ye</span>
###xml 1062 1071 <span type="species:ncbi:10090">nude mice</span>
###xml 1201 1205 <span type="species:ncbi:10090">mice</span>
###xml 1282 1284 <span type="species:ncbi:630">Ye</span>
There is substantial knowledge about IFN-gamma mediated effector mechanisms in host defense against pathogens, such as promotion of TH1 responses, induction of expression of 47 kDa GTPases [33], oxidative burst or antigen presentation [34]; however, the exact effector mechanisms induced by IFN-gamma for clearance of a Yersinia infection are not yet defined. By determining killing of BMDM upon infection with Ye we demonstrate that killing of yersiniae by BMDM is quite efficient. However, in contrast to DeltayopH, pYV+ is less efficiently cleared by BMDM indicating that YopH inhibits killing of yersiniae to some extent. In addition pretreatment of BMDM with IFN-gamma bypasses indirectly or directly YopH mediated resistance of killing of yersiniae. This data further supports the idea that IFN-gamma is not necessarily needed to defeat Yersinia lacking YopH. However, YopH may also exert other immune evasion mechanisms. In fact, YopH also inhibits T cell activation [15-17]. Previous data demonstrates that infection of athymic, T cell deficient C57BL/6 nude mice leads to an increased bacterial number in the spleen starting only three days after infection compared to infection with C57BL/6 mice suggesting that T cell responses are already involved in the early phase of Ye infections [35].
###end p 45
###begin p 46
###xml 777 779 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 878 887 866 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
###xml 897 905 885 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 976 985 960 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
###xml 1178 1182 1150 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH</italic>
###xml 1155 1157 <span type="species:ncbi:630">Ye</span>
Taken together, the data presented herein show that IFN-gamma bypasses or compensates for immune evasion mechanism of YopH. Moreover, we provide evidence that improvement in killing of bacteria by macrophages may represent part of the effector functions of IFN-gamma to compensate for immune evasion mechanisms provided by the interplay of the effector Yops of the Ysc-Yop type three secretion system and that deletion of YopH enables the immune defense to work efficiently without the presence of IFN-gamma. However, further studies need to define whether alterations in the immune response against YopH deletion mutant are solely due to the phosphatase activity of YopH or whether they also may be due to changes in the secretion of some of the other Yops (e.g. YopT, YopP) [36]. Moreover, future studies are needed to define the crucial mechanisms important for clearance of Yersinia infection in vivo and to elucidate which IFN-gamma induced genes are important to bypass Yersinia mediated inhibition of yersiniae killing. However, since beside IFN-gamma other genes such as IL-6, TNF-alpha, IL-12, IL-18 are not necessarily required for clearance of Ye infection with DeltayopH, it can be speculated that YopH does not counteract the effector functions of one of those genes specifically but rather a proinflammatory response in general.
###end p 46
###begin title 47
Methods
###end title 47
###begin title 48
Bacterial strains and plasmids
###end title 48
###begin p 49
###xml 43 44 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 47 49 47 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 114 115 114 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 173 178 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 196 200 188 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH</italic>
###xml 214 216 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 18 20 <span type="species:ncbi:630">Ye</span>
For infection the Ye O:8 strain WA-314 (pYV+) [37], and derivatives of this strain were used. The strain WA-C (pYV-) lacks the pYV virulence plasmid and the strain WA-C pYV yopH Delta17-455 (DeltayopH) lacks YopH [36].
###end p 49
###begin title 50
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse infections
###end title 50
###begin p 51
###xml 41 49 41 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tm1Kopf </italic>
###xml 41 49 41 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>tm1Kopf </italic></sup>
###xml 66 69 66 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 137 141 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ifng</italic>
###xml 141 149 141 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">rtm1agt </sup>
###xml 159 163 155 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 164 166 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 549 551 539 541 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
###xml 343 345 <span type="species:ncbi:630">Ye</span>
###xml 519 523 <span type="species:ncbi:10090">mice</span>
The mouse strains used were C57BL/6j-IL-6tm1Kopf (referred as IL-6-/-) kindly provided by M. Kopf, ETH Zurich, Switzerland [38] C57BL/6J-Ifngrtm1agt IFN-gammaR-/- [39] purchased by Jackson laboratories and corresponding C57BL/6 wild-type mice. Six- to eight-week-old female C57BL/6 mice were infected intravenously with the indicated doses of Ye strains from frozen stock suspensions. The administered dose was determined by plating serial dilutions on Mueller-Hinton agar for 36 h at 27degreesC. For kinetic analysis, mice were asphyxiated using CO2 at various time points post infection. Spleens were aseptically removed and homogenized in 5 ml HBSS-buffer (Hank's Balance solution supplemented with 2% FCS and 10 mM HEPES). To determine the numbers of CFU/organ, serial dilutions of homogenated organs were plated on Mueller-Hinton agar plates. Infection experiments were approved according to German law by the Regierungsprasidium Tubingen (H2/02).
###end p 51
###begin title 52
###xml 26 28 26 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Selection of splenic CD11b+ cells
###end title 52
###begin p 53
###xml 34 36 34 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 132 133 132 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 203 206 203 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 212 215 212 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 644 645 643 644 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 703 705 702 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 833 837 832 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 738 742 <span type="species:ncbi:10090">mice</span>
For the selection of splenic CD11b+ cells for further use in microarray experiments five to ten mice per group were sacrificed by CO2asphyxiation. The spleens were removed and placed in ice-cold HBSS (Ca2+ and Mg2+ free Hanks' balanced salt solution; BioWhittaker, Walkersville, MD), supplemented with 2% FCS (HyClone, Logan, Utah) and 10 mM HEPES buffer. The spleens were forced with a 5 ml syringe pestle through a 100 mum-pore nylon mesh cell strainer (Falcon; BD Biosciences). Red blood cells were lysed from spleen samples by incubating the cell suspensions for 5 min at room temperature in erythrocyte lysis buffer (170 mM Tris, 160 mM NH4Cl, pH 7.4) followed by two washes in ice-cold HBSS. CD11b+ cells from a pool of five to ten mice per group were purified by positive selection using magnetic activated cell sorting (MACS)(R) CD11b MicroBeads (Miltenyi Biotec) according to the manufacturer's instructions. To ensure enrichment values of 96-98% purity, the magnetic separation was performed twice. Cell viability and number were assessed by trypan blue exclusion.
###end p 53
###begin title 54
Flow cytometry
###end title 54
###begin p 55
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 329 332 <span type="species:ncbi:10116">rat</span>
###xml 338 343 <span type="species:ncbi:10090">mouse</span>
###xml 367 370 <span type="species:ncbi:10116">rat</span>
###xml 376 381 <span type="species:ncbi:10090">mouse</span>
###xml 395 398 <span type="species:ncbi:10116">rat</span>
###xml 404 409 <span type="species:ncbi:10090">mouse</span>
###xml 427 430 <span type="species:ncbi:10116">rat</span>
###xml 436 441 <span type="species:ncbi:10090">mouse</span>
###xml 464 467 <span type="species:ncbi:10116">rat</span>
###xml 473 478 <span type="species:ncbi:10090">mouse</span>
###xml 491 494 <span type="species:ncbi:10116">rat</span>
###xml 500 505 <span type="species:ncbi:10090">mouse</span>
###xml 525 528 <span type="species:ncbi:10116">rat</span>
###xml 534 539 <span type="species:ncbi:10090">mouse</span>
###xml 589 594 <span type="species:ncbi:10090">mouse</span>
###xml 608 611 <span type="species:ncbi:10116">rat</span>
###xml 617 622 <span type="species:ncbi:10090">mouse</span>
###xml 723 726 <span type="species:ncbi:10116">rat</span>
###xml 732 737 <span type="species:ncbi:10090">mouse</span>
###xml 758 761 <span type="species:ncbi:10116">rat</span>
###xml 767 772 <span type="species:ncbi:10090">mouse</span>
Splenic single-cell suspensions were obtained as described above. 1 x 106cells were resuspended in 100 mul FACS buffer and stained with surface marker-specific fluorophore-conjugated antibodies (Abs). The following Abs and secondary staining reagents conjugated with different fluorophores were used for flow cytometric studies: rat anti-mouse Ly-6G (Gr-1: RB6-8C5), rat anti-mouse CD4 (RM4-5), rat anti-mouse CD8a (53-6.7) or rat anti-mouse CD45R/B220 (RA3-6B2); rat anti-mouse CD19 (1D3), rat anti-mouse pan-NK-cell (DX5), rat anti-mouse CD3epsilon chain (145-2C11) and the hamster anti-mouse CD11c (HL3), rat anti-mouse CD11b (M1/70), streptavidin-FITC, streptavidin-PE; all from BD Pharmingen, Heidelberg, Germany. The rat anti-mouse F4/80 (CI:A3-1) and rat anti-mouse MARCO (ED31) from Serotec (Serotec, Oxford, UK) were also used. The specificity of the staining was verified by the use of isotype control mAbs. Samples were analyzed on a FACSCalibur flow cytometer (BD Immunocytometry Systems) with gating on the propidium iodide-negative cells.
###end p 55
###begin title 56
Isolation of total RNA and microarray analysis
###end title 56
###begin p 57
###xml 34 36 34 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
Total RNA was extracted from CD11b+ cells derived from a pool of five to ten mice per group using the RNAeasy mini-kit following the manufacturer's instructions (Qiagen, Hilden, Germany). Generation of fragmented cRNA was performed as recently described [40] and used for hybridization onto MG-U74Av2 from Affymetrix (Affymetrix, High Wycombe, UK). Genechips were washed, stained with streptavidin-phycoerythrin and read using a GeneChip Scanner 2500 (Affymetrix) at the IZKF microarray facility, Tubingen.
###end p 57
###begin title 58
Microarray data analysis
###end title 58
###begin p 59
###xml 334 336 334 336 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
Analysis of microarray data was performed using the Affymetrix Microarray Suite 5.0, Affymetrix MicroDB 3.0 and Affymetrix Data Mining Tool 3.0. All array experiments were scaled to a target intensity of 150, otherwise the default values of the Microarray suite were used. Filtering of the results was performed as follows: signal log2 ratios (SLR) of the experiments for each colonization condition and time point was calculated. A median SLR greater than 1.5 or less than -1.5 was considered as significant change. The absolute detection calls and change calls were assigned using the detection p-values or the change p-values. A detection p-value of </= 0.04 was considered as present (P), a detection p-value of > 0.04 and </= 0.06 was considered marginal (M) and a detection p-value > 0.06 was considered absent (A). A change call of increase (I) was assigned with a median change p-value of </= 0.0025 and a change call of marginal increase (MI) was assigned at a median change p-value > 0.0025 to 0.003. Change calls of marginal decrease (MD) were assigned at a median change p-value of >/= 0.997 to < 0.998 and a change call of decrease (D) was assigned at a p-value >/= 0.998. All others were assigned no change (NC). Of the probe sets with a significant SLR that had a change call other than NC in comparison to uninfected and were not absent in both compared groups were retained. Probe sets with an increase but a detection call of A in the infected cells were also discarded. Of the remaining probe sets only those with a signal at least 3 times higher than the average noise were used for further analysis. The magnitude and direction of expression changes were estimated as Signal Log Ratio (SLR). Microarray data have been deposited in NCBIs Gene Expression Omnibus (GEO,  accession number (GSE 11189). For each condition described here one microarray was used.
###end p 59
###begin title 60
Cluster analysis
###end title 60
###begin p 61
For Cluster analysis we used Genesis, release 1.6.0 (Institute for Genomics and Bioinformatics, University of Technology, Graz, ). To analyze the relationship between groups of genes we performed a k-means clustering with a number of 10 clusters and a maximum of 200 iterations. Categorization was based on the NetAffx database .
###end p 61
###begin title 62
Quantitative RT- PCR analysis
###end title 62
###begin p 63
###xml 20 22 20 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 130 132 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 998 1010 963 967 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-&#916;&#916;C</sup>
###xml 1010 1012 967 969 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T </sub>
###xml 1020 1022 977 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1023 1025 980 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 537 542 <span type="species:ncbi:10090">mouse</span>
###xml 567 572 <span type="species:ncbi:10090">mouse</span>
###xml 602 607 <span type="species:ncbi:10090">mouse</span>
###xml 637 642 <span type="species:ncbi:10090">mouse</span>
###xml 671 676 <span type="species:ncbi:10090">mouse</span>
Total RNA from CD11b+ cells was extracted using the RNeasy Mini Kit (Qiagen). 2 mug of RNA were reverse transcribed as described [41]. Real-time RT-PCR was carried out on a GeneAmp 5700 Sequence Detection System (Applied Biosystems, Darmstadt, Germany). Each 20-mul reaction contained 10 mul Platinum Quantitative PCR SuperMix-UDG (Invitrogen, Karlsruhe, Germany), 0.4 mul ROX Reference Dye (Invitrogen, Karlsruhe, Germany), 3.6 mul PCR grade water, 1 mul target gene specific Assay-on-Demand Gene Expression Assay Mix Mm00446190_m1 for mouse IL-6, Mm00443258_m1 for mouse TNF-alpha, Mm00434165_m1 for mouse IL-12 p35, Mm00440265_m1 for mouse MARCO, or Mm00657299_g1 for mouse RPL8 (including primers and dye-labeled hybridization probes; Applied Biosystems, Darmstadt, Germany), and 5 mul cDNA. Thermal cycling conditions for all reactions were as follows: 2 min at 50degreesC, 10 min at 95degreesC, then 40 cycles of 15 s at 95degreesC and 1 min at 60degreesC. Results were quantified using the 2-DeltaDeltaCT method [42,43]. Cytokine mRNA expression levels were normalized to the expression of the houskeeping gene ribosomal protein L8 (RPL8). All PCR experiments were performed in duplicate, and standard deviations were calculated and displayed as error bars.
###end p 63
###begin title 64
Analysis of intracellular survival by CFU assay
###end title 64
###begin p 65
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 92 94 92 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 1290 1292 1277 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 615 619 <span type="species:ncbi:9913">calf</span>
Intracellular survival was determined with modification as previously described [44]. 2 x 105 BMDM resuspended in DMEM (Invitrogen, Karlsruhe, Germany), containing 10% FCS (Sigma, Taufkirchen, Germany), supplemented with Na-pyruvate at 1 mM (Biochrom, Berlin, Germany), and 2 mM L-glutamine (Invitrogen, Karlsruhe, Germany) were seeded into 24 well cell culture plates and incubated overnight. Bacteria were grown overnight at 27degreesC in LB medium and subcultivated for 2 h at 37degreesC. The bacteria were washed twice with PBS and finally diluted as needed in DMEM supplemented with 10% heat inactivated fetal calf serum, 2 mM L-glutamine and 1 mM Na-pyruvate. The bacterial number was diluted to a MOI of 5. After addition of bacteria cell culture plates were centrifuged for 5 minutes at 200 x g to facilitate contact of bacteria. After 15 minutes of infection cells were washed twice with PBS. Some of the wells were used to determine initial number of cell associated bacteria by a CFU assay. To the remaining cells cell culture medium containing 8 mug per ml gentamicin was added. After one hour the medium was removed and complete cell culture medium was added containing 4.5 mg/ml gentamicin. Three or five hours after infection a CFU assay was performed as described recently [44].
###end p 65
###begin title 66
Statistics
###end title 66
###begin p 67
###xml 236 238 236 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
The data shown in the figures are from representative experiments. Differences between mean values were analyzed as indicated using either Wilcoxon Rank test, one way ANOVA analyses or logrank test by using Graph Pad Prism software . A p value of < 0.05 was considered statistically significant.
###end p 67
###begin title 68
Authors' contributions
###end title 68
###begin p 69
###xml 179 188 179 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
GM, EF and PW were equal partners in the production of these findings and all three participated in the design of the study and carried out the infection experiments, ex vivo and in vitro experiments, performed data analyses and helped to draft the manuscript. SM guided and supported performance of the microarray analyses. MB processed the RNA for microarray experiments and performed microarray experiments. IBA participated in the study design, data analysis and draft of the manuscript. EB conceived of the study, carried out the design and coordination and drafted the manuscript.
###end p 69
###begin title 70
Supplementary Material
###end title 70
###begin title 71
Additional file 1
###end title 71
###begin p 72
###xml 27 29 27 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 51 56 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 0 65 0 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Comparison of sublethal pYV<sup>+ </sup>versus sublethal &#916;<italic>yopH </italic>infection</bold>
###xml 123 124 119 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 155 157 151 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 179 181 175 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 212 217 204 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 249 251 241 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 346 348 338 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 364 369 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 181 183 <span type="species:ncbi:630">Ye</span>
###xml 251 253 <span type="species:ncbi:630">Ye</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
Comparison of sublethal pYV+ versus sublethal DeltayopH infection. List of genes which fulfill the criteria that signal log2ratio (SLR) after sublethal pYV+ (infection with 5 x 103 Ye) compared to sublethal DeltayopH infection (infection with 5 x 104 Ye) is > 1.5 or < -1.5. Expression levels of genes after infection with sublethal or lethal pYV+ as well as DeltayopH infection are depicted as fold induction compared to uninfected mice.
###end p 72
###begin p 73
Click here for file
###end p 73
###begin title 74
Additional file 2
###end title 74
###begin p 75
###xml 27 29 27 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 48 53 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 0 62 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Comparison of sublethal pYV<sup>+ </sup>versus lethal &#916;<italic>yopH </italic>infection</bold>
###xml 120 121 116 117 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 152 154 148 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 176 178 172 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 209 214 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 246 248 238 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 343 345 335 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 361 366 349 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopH </italic>
###xml 178 180 <span type="species:ncbi:630">Ye</span>
###xml 248 250 <span type="species:ncbi:630">Ye</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
Comparison of sublethal pYV+ versus lethal DeltayopH infection. List of genes which fulfill the criteria that signal log2ratio (SLR) after sublethal pYV+ (infection with 5 x 103 Ye) compared to sublethal DeltayopH infection (infection with 5 x 106 Ye) is > 1.5 or < -1.5. Expression levels of genes after infection with sublethal or lethal pYV+ as well as DeltayopH infection are depicted as fold induction compared to uninfected mice.
###end p 75
###begin p 76
Click here for file
###end p 76
###begin title 77
Acknowledgements
###end title 77
###begin p 78
We would like to thank Juliane Klenk for outstanding technical assistance and Fiona O'Rourke and Amro Amr for proofreading. This work was supported by the BMBF, National genome research network. GM was supported by a Marie-Curie grant of the EU.
###end p 78
###begin article-title 79
###xml 91 100 91 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
Yersiniosis I: microbiological and clinicoepidemiological aspects of plague and non-plague Yersinia infections
###end article-title 79
###begin article-title 80
###xml 37 46 37 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
Yersiniosis. II: The pathogenesis of Yersinia infections
###end article-title 80
###begin article-title 81
###xml 4 13 4 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
The Yersinia Ysc-Yop 'type III' weaponry
###end article-title 81
###begin article-title 82
###xml 0 28 0 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia pseudotuberculosis </italic>
###xml 0 27 <span type="species:ncbi:633">Yersinia pseudotuberculosis</span>
Yersinia pseudotuberculosis inhibits Fc receptor-mediated phagocytosis in J774 cells
###end article-title 82
###begin article-title 83
###xml 43 67 43 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia enterocolitica </italic>
###xml 43 66 <span type="species:ncbi:630">Yersinia enterocolitica</span>
Role of Yops and adhesins in resistance of Yersinia enterocolitica to phagocytosis
###end article-title 83
###begin article-title 84
###xml 30 39 30 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
The cytotoxic protein YopE of Yersinia obstructs the primary host defence
###end article-title 84
###begin article-title 85
###xml 77 105 77 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia pseudotuberculosis </italic>
###xml 77 104 <span type="species:ncbi:633">Yersinia pseudotuberculosis</span>
Inhibition of the Fc receptor-mediated oxidative burst in macrophages by the Yersinia pseudotuberculosis tyrosine phosphatase
###end article-title 85
###begin article-title 86
###xml 20 29 20 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
Localization of the Yersinia PTPase to focal complexes is an important virulence mechanism
###end article-title 86
###begin article-title 87
###xml 44 53 44 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
Identification of p130Cas as a substrate of Yersinia YopH (Yop51), a bacterial protein tyrosine phosphatase that translocates into mammalian cells and targets focal adhesions
###end article-title 87
###begin article-title 88
YopH dephosphorylates Cas and Fyn-binding protein in macrophages
###end article-title 88
###begin article-title 89
###xml 68 77 68 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
Identification of an amino-terminal substrate-binding domain in the Yersinia tyrosine phosphatase that is required for efficient recognition of focal adhesion targets
###end article-title 89
###begin article-title 90
###xml 35 43 35 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia</italic>
The PTPase YopH inhibits uptake of Yersinia, tyrosine phosphorylation of p130Cas and FAK, and the associated accumulation of these proteins in peripheral focal adhesions
###end article-title 90
###begin article-title 91
###xml 24 33 24 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
Interaction between the Yersinia protein tyrosine phosphatase YopH and eukaryotic Cas/Fyb is an important virulence mechanism
###end article-title 91
###begin article-title 92
YopH prevents monocyte chemoattractant protein 1 expression in macrophages and T-cell proliferation through inactivation of the phosphatidylinositol 3-kinase pathway
###end article-title 92
###begin article-title 93
###xml 50 78 50 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia pseudotuberculosis </italic>
###xml 50 77 <span type="species:ncbi:633">Yersinia pseudotuberculosis</span>
Suppression of T and B lymphocyte activation by a Yersinia pseudotuberculosis virulence factor, yopH
###end article-title 93
###begin article-title 94
###xml 88 97 88 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
Lck dephosphorylation at Tyr-394 and inhibition of T cell antigen receptor signaling by Yersinia phosphatase YopH
###end article-title 94
###begin article-title 95
###xml 66 75 66 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
The adaptor molecules LAT and SLP-76 are specifically targeted by Yersinia to inhibit T cell activation
###end article-title 95
###begin article-title 96
###xml 43 67 43 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia enterocolitica </italic>
###xml 43 66 <span type="species:ncbi:630">Yersinia enterocolitica</span>
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
Contribution of the major secreted yops of Yersinia enterocolitica O:8 to pathogenicity in the mouse infection model
###end article-title 96
###begin article-title 97
###xml 11 35 11 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia enterocolitica </italic>
###xml 11 34 <span type="species:ncbi:630">Yersinia enterocolitica</span>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
Attenuated Yersinia enterocolitica mutant strains exhibit differential virulence in cytokine-deficient mice: implications for the development of novel live carrier vaccines
###end article-title 97
###begin article-title 98
###xml 50 78 50 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia pseudotuberculosis </italic>
###xml 50 77 <span type="species:ncbi:633">Yersinia pseudotuberculosis</span>
The proinflammatory response induced by wild-type Yersinia pseudotuberculosis infection inhibits survival of yop mutants in the gastrointestinal tract and Peyer's patches
###end article-title 98
###begin article-title 99
###xml 19 47 19 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia pseudotuberculosis </italic>
###xml 19 46 <span type="species:ncbi:633">Yersinia pseudotuberculosis</span>
Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues
###end article-title 99
###begin article-title 100
###xml 36 60 36 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia enterocolitica </italic>
###xml 36 59 <span type="species:ncbi:630">Yersinia enterocolitica</span>
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
Ambiguous role of interleukin-12 in Yersinia enterocolitica infection in susceptible and resistant mouse strains
###end article-title 100
###begin article-title 101
###xml 40 64 40 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia enterocolitica </italic>
###xml 40 63 <span type="species:ncbi:630">Yersinia enterocolitica</span>
Protective role of interleukin-6 during Yersinia enterocolitica infection is mediated through the modulation of inflammatory cytokines
###end article-title 101
###begin article-title 102
###xml 30 38 30 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia</italic>
Resistance to phagocytosis by Yersinia
###end article-title 102
###begin article-title 103
The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles
###end article-title 103
###begin article-title 104
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression
###end article-title 104
###begin article-title 105
###xml 0 24 0 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia enterocolitica </italic>
###xml 0 23 <span type="species:ncbi:630">Yersinia enterocolitica</span>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice
###end article-title 105
###begin article-title 106
###xml 112 117 <span type="species:ncbi:10090">mouse</span>
A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence
###end article-title 106
###begin article-title 107
Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells
###end article-title 107
###begin article-title 108
Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine
###end article-title 108
###begin article-title 109
Chemokines in immunity
###end article-title 109
###begin article-title 110
###xml 96 120 96 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia enterocolitica </italic>
###xml 96 119 <span type="species:ncbi:630">Yersinia enterocolitica</span>
Histamine signaling through the H(2) receptor in the Peyer's patch is important for controlling Yersinia enterocolitica infection
###end article-title 110
###begin article-title 111
p47 GTPases: regulators of immunity to intracellular pathogens
###end article-title 111
###begin article-title 112
Interferon-gamma activation of polymorphonuclear neutrophil function
###end article-title 112
###begin article-title 113
###xml 13 37 13 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia enterocolitica </italic>
###xml 13 36 <span type="species:ncbi:630">Yersinia enterocolitica</span>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
Experimental Yersinia enterocolitica infection in euthymic and T- cell-deficient athymic nude C57BL/6 mice: comparison of time course, histomorphology, and immune response
###end article-title 113
###begin article-title 114
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia </italic>
Yersinia outer proteins E, H, P, and T differentially target the cytoskeleton and inhibit phagocytic capacity of dendritic cells
###end article-title 114
###begin article-title 115
###xml 30 54 30 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia enterocolitica </italic>
###xml 30 53 <span type="species:ncbi:630">Yersinia enterocolitica</span>
Construction of a mobilizable Yersinia enterocolitica virulence plasmid
###end article-title 115
###begin article-title 116
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Impaired immune and acute-phase responses in interleukin-6-deficient mice
###end article-title 116
###begin article-title 117
###xml 19 23 <span type="species:ncbi:10090">mice</span>
Immune response in mice that lack the interferon-gamma receptor
###end article-title 117
###begin article-title 118
###xml 83 106 83 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia enterocolitica</italic>
###xml 83 106 <span type="species:ncbi:630">Yersinia enterocolitica</span>
Gene expression patterns of epithelial cells modulated by pathogenicity factors of Yersinia enterocolitica
###end article-title 118
###begin article-title 119
###xml 0 23 0 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia enterocolitica</italic>
###xml 0 23 <span type="species:ncbi:630">Yersinia enterocolitica</span>
###xml 59 64 <span type="species:ncbi:9606">human</span>
Yersinia enterocolitica-induced interleukin-8 secretion by human intestinal epithelial cells depends on cell differentiation
###end article-title 119
###begin article-title 120
A new mathematical model for relative quantification in real-time RT-PCR
###end article-title 120
###begin article-title 121
Real-time quantitative PCR
###end article-title 121
###begin article-title 122
###xml 31 58 <span type="species:ncbi:633">Yersinia pseudotuberculosis</span>
The response regulator PhoP of Yersinia pseudotuberculosis is important for replication in macrophages and for virulence
###end article-title 122

